When we further analyzed EV antigen profiles in samples from AML patients, we detected expression of CD133 and CD44, two hematopoietic stem/progenitor cell markers, as well as the type I transmembrane protein CD105 in samples where the leukemic blasts expressed these antigens (Figure 5C, middle panel). Here, CD44 is linked to acute myeloid leukemia.